Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxa2
|
ENSMUSG00000037025.5 | forkhead box A2 |
Foxa1
|
ENSMUSG00000035451.6 | forkhead box A1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_57545950_57546156 | Foxa1 | 68 | 0.966337 | 0.70 | 3.2e-09 | Click! |
chr12_57546637_57547126 | Foxa1 | 35 | 0.970426 | 0.65 | 8.8e-08 | Click! |
chr12_57537131_57537289 | Foxa1 | 8911 | 0.149504 | 0.58 | 3.5e-06 | Click! |
chr12_57546323_57546579 | Foxa1 | 330 | 0.858449 | 0.56 | 1.1e-05 | Click! |
chr12_57545497_57545878 | Foxa1 | 434 | 0.793485 | 0.50 | 1.2e-04 | Click! |
chr2_148046824_148046983 | Foxa2 | 7 | 0.973079 | 0.77 | 6.5e-12 | Click! |
chr2_148045489_148046522 | Foxa2 | 57 | 0.969442 | 0.74 | 9.3e-11 | Click! |
chr2_148046536_148046746 | Foxa2 | 255 | 0.904352 | 0.62 | 4.8e-07 | Click! |
chr2_148047071_148047222 | Foxa2 | 177 | 0.938381 | 0.60 | 1.3e-06 | Click! |
chr2_148048526_148048736 | Foxa2 | 1662 | 0.317058 | 0.42 | 1.6e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_95855291_95855553 | 39.27 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
9652 |
0.19 |
chr11_86587246_86587688 | 37.59 |
Vmp1 |
vacuole membrane protein 1 |
473 |
0.75 |
chr5_109557850_109558797 | 37.57 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr1_162891926_162892449 | 34.15 |
Fmo2 |
flavin containing monooxygenase 2 |
5672 |
0.19 |
chr11_96929113_96929565 | 31.36 |
Prr15l |
proline rich 15-like |
15 |
0.95 |
chr11_79771332_79771811 | 29.78 |
9130204K15Rik |
RIKEN cDNA 9130204K15 gene |
11316 |
0.16 |
chr9_70237723_70237889 | 29.67 |
Myo1e |
myosin IE |
30438 |
0.18 |
chr11_85775247_85775913 | 29.57 |
Bcas3os2 |
breast carcinoma amplified sequence 3 opposite strand 2 |
100 |
0.95 |
chr6_72293058_72293242 | 28.23 |
Sftpb |
surfactant associated protein B |
11460 |
0.13 |
chr9_75236923_75237234 | 27.66 |
Myo5c |
myosin VC |
5002 |
0.19 |
chr9_67235542_67235843 | 26.00 |
Mir190a |
microRNA 190a |
1034 |
0.55 |
chr16_90779900_90780106 | 25.95 |
Urb1 |
URB1 ribosome biogenesis 1 homolog (S. cerevisiae) |
7212 |
0.16 |
chr10_115817172_115817352 | 25.42 |
Tspan8 |
tetraspanin 8 |
9 |
0.99 |
chr7_126746842_126747128 | 25.23 |
Gm44855 |
predicted gene 44855 |
2570 |
0.09 |
chr2_75632701_75632852 | 25.10 |
Gm13655 |
predicted gene 13655 |
606 |
0.69 |
chr1_37041206_37041380 | 25.06 |
Vwa3b |
von Willebrand factor A domain containing 3B |
5585 |
0.2 |
chr9_61808528_61808859 | 24.97 |
Gm19208 |
predicted gene, 19208 |
43011 |
0.15 |
chr8_40572970_40573513 | 24.88 |
Mtmr7 |
myotubularin related protein 7 |
17273 |
0.16 |
chr7_16792307_16792658 | 24.06 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
545 |
0.64 |
chr2_29677911_29678077 | 23.84 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
24488 |
0.15 |
chr4_150685197_150685518 | 23.73 |
Gm16079 |
predicted gene 16079 |
6565 |
0.21 |
chr4_141131586_141132124 | 23.72 |
Szrd1 |
SUZ RNA binding domain containing 1 |
7872 |
0.11 |
chr13_111397493_111397892 | 23.68 |
Gm6270 |
predicted gene 6270 |
29012 |
0.14 |
chr4_139387042_139387343 | 23.47 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
6523 |
0.12 |
chr7_143769581_143769748 | 23.33 |
Mrgprg |
MAS-related GPR, member G |
2671 |
0.15 |
chr3_144201827_144203140 | 22.97 |
Lmo4 |
LIM domain only 4 |
87 |
0.97 |
chr17_35164786_35165560 | 22.30 |
Gm17705 |
predicted gene, 17705 |
54 |
0.72 |
chr10_125270360_125270601 | 22.25 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
38336 |
0.18 |
chr11_78408424_78408863 | 22.14 |
Slc13a2 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
13574 |
0.09 |
chr11_115912151_115912342 | 22.12 |
Smim6 |
small integral membrane protein 6 |
229 |
0.85 |
chr14_76733384_76733551 | 22.07 |
4930431P22Rik |
RIKEN cDNA 4930431P22 gene |
26664 |
0.17 |
chr7_132308529_132308892 | 21.90 |
Gm44891 |
predicted gene 44891 |
5368 |
0.15 |
chr6_49148881_49149069 | 21.69 |
Gm18010 |
predicted gene, 18010 |
23784 |
0.12 |
chr9_70240765_70241033 | 20.99 |
Myo1e |
myosin IE |
33531 |
0.17 |
chr11_116506385_116506879 | 20.98 |
Rpl36-ps1 |
ribosomal protein L36, pseudogene 1 |
2096 |
0.17 |
chr6_87127175_87127331 | 20.91 |
Gm44415 |
predicted gene, 44415 |
13599 |
0.15 |
chr5_134209968_134210175 | 20.70 |
Gtf2ird2 |
GTF2I repeat domain containing 2 |
3414 |
0.16 |
chr11_97434692_97435371 | 20.68 |
Arhgap23 |
Rho GTPase activating protein 23 |
1254 |
0.42 |
chr7_45708987_45709454 | 20.47 |
Dbp |
D site albumin promoter binding protein |
1331 |
0.17 |
chr1_167802317_167803268 | 20.43 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
113235 |
0.07 |
chr10_28228262_28228413 | 20.31 |
Gm22370 |
predicted gene, 22370 |
14216 |
0.29 |
chr11_83877867_83878041 | 19.98 |
Hnf1b |
HNF1 homeobox B |
24994 |
0.13 |
chr10_115816613_115816915 | 19.94 |
Tspan8 |
tetraspanin 8 |
68 |
0.98 |
chr19_43999221_43999522 | 19.93 |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
12815 |
0.14 |
chr1_21231877_21232055 | 19.81 |
Gm38224 |
predicted gene, 38224 |
2756 |
0.17 |
chr6_72272236_72272936 | 19.79 |
Sftpb |
surfactant associated protein B |
32024 |
0.11 |
chr15_97229797_97229962 | 19.75 |
Pced1b |
PC-esterase domain containing 1B |
17228 |
0.19 |
chr8_94354649_94354841 | 19.34 |
Slc12a3 |
solute carrier family 12, member 3 |
301 |
0.82 |
chr12_79541656_79541860 | 19.34 |
Rad51b |
RAD51 paralog B |
214405 |
0.02 |
chr1_64809148_64809517 | 19.25 |
Plekhm3 |
pleckstrin homology domain containing, family M, member 3 |
27432 |
0.16 |
chr18_62176635_62176796 | 19.16 |
Adrb2 |
adrenergic receptor, beta 2 |
3244 |
0.24 |
chr9_108301892_108302239 | 19.15 |
Tcta |
T cell leukemia translocation altered gene |
3883 |
0.09 |
chr17_47914586_47915244 | 19.10 |
Gm15556 |
predicted gene 15556 |
7463 |
0.14 |
chr3_104289400_104289566 | 18.99 |
Magi3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
69109 |
0.06 |
chr2_170270298_170270480 | 18.89 |
Gm14270 |
predicted gene 14270 |
14646 |
0.23 |
chr6_30693996_30694444 | 18.70 |
Cep41 |
centrosomal protein 41 |
471 |
0.72 |
chr6_115463466_115463621 | 18.56 |
Gm44079 |
predicted gene, 44079 |
1447 |
0.4 |
chr11_109488104_109488259 | 18.55 |
Arsg |
arylsulfatase G |
2575 |
0.19 |
chr6_82956881_82957091 | 18.53 |
Gm19287 |
predicted gene, 19287 |
4206 |
0.11 |
chr7_141476252_141476671 | 18.51 |
Tspan4 |
tetraspanin 4 |
61 |
0.91 |
chr10_96188216_96188449 | 18.44 |
Gm22913 |
predicted gene, 22913 |
24001 |
0.15 |
chr11_16800630_16801057 | 18.39 |
Egfros |
epidermal growth factor receptor, opposite strand |
29859 |
0.17 |
chr7_49195732_49195929 | 18.38 |
Gm37613 |
predicted gene, 37613 |
289 |
0.92 |
chr13_104037534_104037876 | 18.33 |
Nln |
neurolysin (metallopeptidase M3 family) |
63 |
0.98 |
chr6_90624330_90624518 | 18.32 |
Slc41a3 |
solute carrier family 41, member 3 |
5277 |
0.15 |
chrX_53205020_53205171 | 18.13 |
Plac1 |
placental specific protein 1 |
4629 |
0.21 |
chr1_153988420_153988604 | 18.10 |
Gm29291 |
predicted gene 29291 |
17705 |
0.14 |
chr8_106135634_106135976 | 18.09 |
1810019D21Rik |
RIKEN cDNA 1810019D21 gene |
370 |
0.64 |
chr6_59014876_59015038 | 18.06 |
Fam13a |
family with sequence similarity 13, member A |
9383 |
0.16 |
chr11_75925837_75926169 | 18.04 |
Rph3al |
rabphilin 3A-like (without C2 domains) |
112 |
0.97 |
chr5_73193736_73193919 | 17.96 |
Fryl |
FRY like transcription coactivator |
1948 |
0.23 |
chr18_64850466_64850770 | 17.91 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
37087 |
0.12 |
chr11_8503775_8504139 | 17.64 |
Tns3 |
tensin 3 |
35282 |
0.23 |
chr13_34299446_34299869 | 17.50 |
Gm47086 |
predicted gene, 47086 |
19151 |
0.18 |
chr3_24783133_24783464 | 17.38 |
Naaladl2 |
N-acetylated alpha-linked acidic dipeptidase-like 2 |
324 |
0.94 |
chr6_113690640_113690849 | 17.16 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
1 |
0.91 |
chr14_60257239_60257405 | 17.07 |
Gm49336 |
predicted gene, 49336 |
5815 |
0.14 |
chr7_114232116_114232267 | 16.99 |
Copb1 |
coatomer protein complex, subunit beta 1 |
14030 |
0.19 |
chr14_59552127_59552278 | 16.97 |
Cdadc1 |
cytidine and dCMP deaminase domain containing 1 |
45634 |
0.12 |
chr8_119740726_119740933 | 16.91 |
Gm45747 |
predicted gene 45747 |
26375 |
0.12 |
chr5_147299227_147299912 | 16.81 |
Cdx2 |
caudal type homeobox 2 |
7701 |
0.1 |
chr1_182256144_182256327 | 16.73 |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
25989 |
0.15 |
chr13_56153187_56153343 | 16.69 |
Gm25148 |
predicted gene, 25148 |
14335 |
0.14 |
chr18_24102564_24102822 | 16.64 |
Ino80c |
INO80 complex subunit C |
12220 |
0.18 |
chr17_50389526_50389678 | 16.47 |
Gm49906 |
predicted gene, 49906 |
50350 |
0.14 |
chr13_56747606_56747757 | 16.39 |
Gm45623 |
predicted gene 45623 |
6146 |
0.23 |
chr11_115901012_115901222 | 16.36 |
Smim5 |
small integral membrane protein 5 |
915 |
0.36 |
chr7_98048253_98048538 | 16.35 |
Myo7a |
myosin VIIA |
16807 |
0.21 |
chr12_76271526_76271782 | 16.27 |
Gm47526 |
predicted gene, 47526 |
6062 |
0.12 |
chr3_60169438_60169604 | 16.23 |
Gm24382 |
predicted gene, 24382 |
41774 |
0.16 |
chr9_103090078_103090422 | 16.16 |
Gm47468 |
predicted gene, 47468 |
4713 |
0.18 |
chr13_59615643_59615812 | 16.14 |
Naa35 |
N(alpha)-acetyltransferase 35, NatC auxiliary subunit |
2184 |
0.21 |
chr10_37260912_37261063 | 16.11 |
4930543K20Rik |
RIKEN cDNA 4930543K20 gene |
2761 |
0.36 |
chr7_112966871_112967022 | 16.10 |
Gm5599 |
predicted gene 5599 |
5937 |
0.2 |
chr1_131108002_131108306 | 16.09 |
Mapkapk2 |
MAP kinase-activated protein kinase 2 |
10328 |
0.13 |
chr3_60472720_60472916 | 16.08 |
Mbnl1 |
muscleblind like splicing factor 1 |
12 |
0.99 |
chr6_22074603_22074791 | 16.07 |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
48754 |
0.17 |
chr4_126155903_126156318 | 16.06 |
Sh3d21 |
SH3 domain containing 21 |
6491 |
0.11 |
chr2_155369582_155369733 | 15.99 |
Trp53inp2 |
transformation related protein 53 inducible nuclear protein 2 |
11402 |
0.13 |
chr13_20132090_20132277 | 15.95 |
Elmo1 |
engulfment and cell motility 1 |
20671 |
0.26 |
chr15_41846165_41846316 | 15.94 |
Oxr1 |
oxidation resistance 1 |
3984 |
0.24 |
chr9_85769513_85769696 | 15.84 |
Gm22830 |
predicted gene, 22830 |
2876 |
0.19 |
chr11_59432345_59432521 | 15.76 |
Snap47 |
synaptosomal-associated protein, 47 |
15058 |
0.1 |
chr3_96220445_96221400 | 15.74 |
H2ac20 |
H2A clustered histone 20 |
42 |
0.58 |
chr9_65554703_65554909 | 15.67 |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
7358 |
0.14 |
chr2_71083882_71084235 | 15.64 |
Dcaf17 |
DDB1 and CUL4 associated factor 17 |
8716 |
0.2 |
chr10_117106272_117106596 | 15.62 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
24412 |
0.12 |
chr2_163586914_163587109 | 15.60 |
Ttpal |
tocopherol (alpha) transfer protein-like |
15303 |
0.13 |
chr10_125951750_125951901 | 15.59 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
14343 |
0.28 |
chr6_38919209_38919401 | 15.59 |
Tbxas1 |
thromboxane A synthase 1, platelet |
281 |
0.92 |
chr7_27291768_27292241 | 15.57 |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
14966 |
0.09 |
chr14_99281537_99281688 | 15.55 |
Gm4412 |
predicted gene 4412 |
10024 |
0.18 |
chr11_99489442_99489614 | 15.54 |
Krt23 |
keratin 23 |
3609 |
0.12 |
chr2_69818805_69818994 | 15.53 |
Klhl23 |
kelch-like 23 |
3045 |
0.15 |
chr11_79281169_79281320 | 15.51 |
Gm44787 |
predicted gene 44787 |
7351 |
0.16 |
chr10_100073268_100073419 | 15.48 |
Kitl |
kit ligand |
14713 |
0.18 |
chr18_64182836_64182987 | 15.46 |
St8sia3os |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3, opposite strand |
14107 |
0.15 |
chr8_84741000_84741151 | 15.46 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
18068 |
0.1 |
chr7_125478687_125478971 | 15.42 |
Nsmce1 |
NSE1 homolog, SMC5-SMC6 complex component |
270 |
0.91 |
chr4_59292306_59292644 | 15.41 |
Susd1 |
sushi domain containing 1 |
23491 |
0.17 |
chr9_116389002_116389158 | 15.36 |
D730003K21Rik |
RIKEN cDNA D730003K21 gene |
57912 |
0.15 |
chr5_92763677_92764030 | 15.19 |
Mir1961 |
microRNA 1961 |
24709 |
0.16 |
chr2_178471923_178472101 | 15.14 |
Cdh26 |
cadherin-like 26 |
11382 |
0.22 |
chr6_37617523_37617974 | 14.99 |
Ybx1-ps2 |
Y box protein 1, pseudogene 2 |
69447 |
0.1 |
chr3_118594373_118594524 | 14.85 |
Dpyd |
dihydropyrimidine dehydrogenase |
32262 |
0.16 |
chr9_122188851_122189055 | 14.75 |
Ano10 |
anoctamin 10 |
1334 |
0.36 |
chr8_44705001_44705152 | 14.71 |
Gm26089 |
predicted gene, 26089 |
103243 |
0.07 |
chr18_76119611_76119809 | 14.70 |
2900057B20Rik |
RIKEN cDNA 2900057B20 gene |
21239 |
0.19 |
chr10_98504531_98504809 | 14.66 |
Gm37631 |
predicted gene, 37631 |
17797 |
0.23 |
chr16_21831870_21832054 | 14.65 |
Gm49607 |
predicted gene, 49607 |
4593 |
0.13 |
chr4_132198306_132198494 | 14.61 |
Ythdf2 |
YTH N6-methyladenosine RNA binding protein 2 |
12409 |
0.09 |
chr1_90969551_90969811 | 14.61 |
Rab17 |
RAB17, member RAS oncogene family |
20 |
0.97 |
chr8_106611054_106611250 | 14.56 |
Cdh1 |
cadherin 1 |
7009 |
0.18 |
chr16_97594205_97594628 | 14.54 |
Tmprss2 |
transmembrane protease, serine 2 |
3515 |
0.25 |
chr15_97042032_97042236 | 14.53 |
Slc38a4 |
solute carrier family 38, member 4 |
7953 |
0.28 |
chr6_99171957_99172205 | 14.50 |
Foxp1 |
forkhead box P1 |
9063 |
0.29 |
chr10_24638296_24638624 | 14.47 |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
35798 |
0.13 |
chr3_21895662_21895829 | 14.45 |
7530428D23Rik |
RIKEN cDNA 7530428D23 gene |
94972 |
0.07 |
chr6_86765617_86765810 | 14.45 |
Anxa4 |
annexin A4 |
94 |
0.96 |
chr8_61397274_61397458 | 14.38 |
Gm7432 |
predicted gene 7432 |
15979 |
0.18 |
chr5_116023179_116023683 | 14.31 |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
925 |
0.45 |
chr8_105226068_105226278 | 14.28 |
D230025D16Rik |
RIKEN cDNA D230025D16 gene |
906 |
0.35 |
chr8_107886012_107886340 | 14.28 |
5033426E14Rik |
RIKEN cDNA 5033426E14 gene |
16491 |
0.19 |
chr10_125785483_125786054 | 14.27 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
180400 |
0.03 |
chr11_73175718_73175883 | 14.26 |
Emc6 |
ER membrane protein complex subunit 6 |
1202 |
0.25 |
chr17_12792615_12792849 | 14.24 |
Gm49959 |
predicted gene, 49959 |
1072 |
0.34 |
chr2_26957538_26957707 | 14.22 |
Rexo4 |
REX4, 3'-5' exonuclease |
1036 |
0.3 |
chr11_87126714_87127907 | 14.22 |
Trim37 |
tripartite motif-containing 37 |
5 |
0.84 |
chr4_119028467_119028820 | 14.19 |
Gm12862 |
predicted gene 12862 |
28158 |
0.08 |
chr17_56277144_56277526 | 14.19 |
Ticam1 |
toll-like receptor adaptor molecule 1 |
549 |
0.58 |
chr1_59503746_59503907 | 14.13 |
Gm26813 |
predicted gene, 26813 |
11221 |
0.13 |
chr18_37933505_37933703 | 14.12 |
Diaph1 |
diaphanous related formin 1 |
1777 |
0.18 |
chr14_76520643_76520912 | 14.11 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
5815 |
0.21 |
chr12_79598609_79598769 | 14.09 |
Rad51b |
RAD51 paralog B |
271336 |
0.01 |
chr4_80895358_80895537 | 14.08 |
Lurap1l |
leucine rich adaptor protein 1-like |
15199 |
0.24 |
chr18_64646756_64647037 | 14.07 |
Atp8b1 |
ATPase, class I, type 8B, member 1 |
13911 |
0.14 |
chr6_120807828_120807988 | 14.06 |
Atp6v1e1 |
ATPase, H+ transporting, lysosomal V1 subunit E1 |
5486 |
0.15 |
chr1_66996917_66997115 | 14.03 |
Lancl1 |
LanC (bacterial lantibiotic synthetase component C)-like 1 |
24049 |
0.14 |
chr19_34657030_34657217 | 13.99 |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
16252 |
0.11 |
chr2_75768336_75768540 | 13.99 |
Gm13657 |
predicted gene 13657 |
8750 |
0.15 |
chr6_121622408_121622584 | 13.99 |
Gm43945 |
predicted gene, 43945 |
3216 |
0.22 |
chr7_129876853_129877077 | 13.98 |
Gm44778 |
predicted gene 44778 |
43919 |
0.18 |
chr7_114103728_114104007 | 13.95 |
Rras2 |
related RAS viral (r-ras) oncogene 2 |
13897 |
0.21 |
chr17_25064442_25064603 | 13.87 |
Tmem204 |
transmembrane protein 204 |
13702 |
0.11 |
chr11_87750589_87750762 | 13.87 |
Mir142hg |
Mir142 host gene (non-protein coding) |
4902 |
0.1 |
chr1_67116639_67117125 | 13.85 |
Cps1 |
carbamoyl-phosphate synthetase 1 |
6144 |
0.25 |
chr14_60993588_60993857 | 13.85 |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
17837 |
0.22 |
chr5_92745758_92746287 | 13.85 |
Gm20500 |
predicted gene 20500 |
9817 |
0.19 |
chr5_30256041_30256196 | 13.81 |
Selenoi |
selenoprotein I |
6946 |
0.15 |
chr9_68825925_68826186 | 13.80 |
Rora |
RAR-related orphan receptor alpha |
170752 |
0.03 |
chr18_69225050_69225299 | 13.80 |
Gm4402 |
predicted gene 4402 |
7673 |
0.17 |
chr11_100391117_100391590 | 13.77 |
Jup |
junction plakoglobin |
4583 |
0.09 |
chr9_61808875_61809108 | 13.76 |
Gm19208 |
predicted gene, 19208 |
42713 |
0.15 |
chr14_48476338_48476652 | 13.75 |
Tmem260 |
transmembrane protein 260 |
3058 |
0.21 |
chr12_16870883_16871072 | 13.74 |
Gm36495 |
predicted gene, 36495 |
20096 |
0.13 |
chr6_82030100_82030461 | 13.73 |
Eva1a |
eva-1 homolog A (C. elegans) |
10763 |
0.15 |
chr3_95675100_95675744 | 13.71 |
Adamtsl4 |
ADAMTS-like 4 |
1729 |
0.22 |
chr1_91490299_91490493 | 13.67 |
Gm19085 |
predicted gene, 19085 |
387 |
0.77 |
chr11_97850447_97850902 | 13.63 |
Fbxo47 |
F-box protein 47 |
4878 |
0.11 |
chr9_121422523_121422859 | 13.63 |
Trak1 |
trafficking protein, kinesin binding 1 |
6716 |
0.2 |
chr1_133966142_133966321 | 13.62 |
Gm1627 |
predicted gene 1627 |
4069 |
0.18 |
chr7_49284064_49284267 | 13.59 |
Nav2 |
neuron navigator 2 |
19973 |
0.22 |
chr11_3398429_3398724 | 13.56 |
Limk2 |
LIM motif-containing protein kinase 2 |
10598 |
0.12 |
chr11_17768900_17769081 | 13.51 |
Gm12016 |
predicted gene 12016 |
129807 |
0.05 |
chr19_7581042_7581193 | 13.43 |
Plaat3 |
phospholipase A and acyltransferase 3 |
23632 |
0.12 |
chr13_104641151_104641346 | 13.40 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
43683 |
0.19 |
chr2_73056222_73056429 | 13.40 |
Gm13665 |
predicted gene 13665 |
60423 |
0.08 |
chr2_164733298_164733449 | 13.37 |
Wfdc3 |
WAP four-disulfide core domain 3 |
9939 |
0.07 |
chr19_61057665_61057910 | 13.36 |
Gm22520 |
predicted gene, 22520 |
44242 |
0.12 |
chr6_99173700_99173851 | 13.35 |
Foxp1 |
forkhead box P1 |
10757 |
0.29 |
chr11_24569735_24569998 | 13.33 |
Gm22787 |
predicted gene, 22787 |
15808 |
0.2 |
chr17_85056831_85056982 | 13.30 |
Prepl |
prolyl endopeptidase-like |
20568 |
0.16 |
chr10_19631711_19631874 | 13.30 |
Il22ra2 |
interleukin 22 receptor, alpha 2 |
9794 |
0.17 |
chr10_20046153_20046446 | 13.29 |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
53226 |
0.13 |
chr4_115996903_115997211 | 13.28 |
Faah |
fatty acid amide hydrolase |
2880 |
0.2 |
chr4_80874240_80874452 | 13.27 |
Tyrp1 |
tyrosinase-related protein 1 |
27758 |
0.21 |
chr11_108365301_108365475 | 13.27 |
Gm11656 |
predicted gene 11656 |
12489 |
0.16 |
chr11_61685495_61685761 | 13.24 |
Fam83g |
family with sequence similarity 83, member G |
1209 |
0.43 |
chr5_103499408_103499559 | 13.21 |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
30083 |
0.16 |
chr6_30437129_30437280 | 13.21 |
Klhdc10 |
kelch domain containing 10 |
6566 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 22.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
7.0 | 21.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
5.6 | 16.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
5.2 | 15.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
5.0 | 5.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
4.6 | 13.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
4.5 | 17.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
4.3 | 12.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
4.1 | 12.4 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
4.0 | 12.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
4.0 | 12.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
4.0 | 15.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
3.8 | 19.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
3.8 | 11.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.5 | 14.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
3.5 | 10.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
3.4 | 10.3 | GO:0060066 | oviduct development(GO:0060066) |
3.4 | 23.7 | GO:0015825 | L-serine transport(GO:0015825) |
3.4 | 30.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
3.3 | 10.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
3.3 | 9.9 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
3.2 | 9.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
3.2 | 9.6 | GO:0002086 | diaphragm contraction(GO:0002086) |
3.1 | 6.2 | GO:0061511 | centriole elongation(GO:0061511) |
3.1 | 9.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
3.1 | 9.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
3.0 | 9.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
3.0 | 5.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.9 | 8.8 | GO:0006106 | fumarate metabolic process(GO:0006106) |
2.9 | 8.6 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
2.8 | 8.5 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
2.8 | 2.8 | GO:0001840 | neural plate development(GO:0001840) |
2.8 | 8.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.8 | 8.3 | GO:0032439 | endosome localization(GO:0032439) |
2.8 | 11.0 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
2.8 | 8.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.7 | 27.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
2.7 | 8.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.7 | 8.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
2.7 | 5.3 | GO:0021564 | vagus nerve development(GO:0021564) |
2.6 | 13.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
2.6 | 7.8 | GO:0032252 | secretory granule localization(GO:0032252) |
2.6 | 7.7 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
2.6 | 7.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
2.5 | 12.6 | GO:0080009 | mRNA methylation(GO:0080009) |
2.5 | 12.5 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
2.5 | 2.5 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
2.5 | 7.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
2.4 | 4.8 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
2.4 | 9.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.4 | 7.2 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.3 | 2.3 | GO:0001705 | ectoderm formation(GO:0001705) |
2.3 | 32.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
2.3 | 9.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
2.3 | 6.8 | GO:0032782 | bile acid secretion(GO:0032782) |
2.2 | 6.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.2 | 8.8 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
2.1 | 10.7 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
2.1 | 6.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
2.1 | 8.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
2.1 | 21.3 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
2.1 | 12.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
2.1 | 8.4 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
2.1 | 6.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
2.1 | 2.1 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
2.1 | 2.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
2.1 | 16.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
2.1 | 6.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.1 | 12.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
2.0 | 8.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
2.0 | 10.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
2.0 | 6.1 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
2.0 | 74.5 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
2.0 | 6.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
2.0 | 15.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
2.0 | 6.0 | GO:0060374 | mast cell differentiation(GO:0060374) |
2.0 | 11.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.9 | 5.8 | GO:1903011 | negative regulation of bone development(GO:1903011) |
1.9 | 5.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.9 | 9.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.9 | 9.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.9 | 1.9 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.9 | 5.6 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
1.9 | 13.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.9 | 3.7 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.9 | 5.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.8 | 5.5 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.8 | 5.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.8 | 14.5 | GO:0033194 | response to hydroperoxide(GO:0033194) |
1.8 | 1.8 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
1.8 | 10.9 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.8 | 1.8 | GO:0070384 | Harderian gland development(GO:0070384) |
1.8 | 7.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.8 | 12.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.8 | 3.5 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.8 | 7.0 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.7 | 19.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
1.7 | 5.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.7 | 1.7 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.7 | 6.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.7 | 1.7 | GO:0003284 | septum primum development(GO:0003284) |
1.7 | 8.6 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
1.7 | 5.1 | GO:0009629 | response to gravity(GO:0009629) |
1.7 | 13.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.7 | 5.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.7 | 1.7 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
1.7 | 5.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.7 | 34.7 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.6 | 4.9 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.6 | 8.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.6 | 4.9 | GO:0021590 | cerebellum maturation(GO:0021590) |
1.6 | 4.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.6 | 16.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.6 | 11.3 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
1.6 | 8.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.6 | 1.6 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
1.6 | 4.8 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
1.6 | 4.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.6 | 3.2 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
1.6 | 1.6 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.6 | 9.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.6 | 1.6 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
1.6 | 4.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.6 | 4.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.6 | 4.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.6 | 9.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.5 | 12.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.5 | 3.0 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.5 | 6.1 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.5 | 6.0 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
1.5 | 3.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.5 | 7.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.5 | 1.5 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.5 | 6.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.5 | 4.4 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.5 | 1.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.5 | 4.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.5 | 2.9 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
1.5 | 4.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
1.4 | 5.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.4 | 4.3 | GO:0015888 | thiamine transport(GO:0015888) |
1.4 | 5.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.4 | 5.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.4 | 4.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.4 | 2.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.4 | 7.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.4 | 5.6 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
1.4 | 1.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.4 | 1.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.4 | 4.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.4 | 4.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.4 | 2.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
1.4 | 15.2 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
1.4 | 2.8 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.4 | 15.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.4 | 2.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.3 | 4.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.3 | 5.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.3 | 4.0 | GO:0007494 | midgut development(GO:0007494) |
1.3 | 4.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.3 | 2.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.3 | 2.7 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) positive regulation of ATP biosynthetic process(GO:2001171) |
1.3 | 1.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.3 | 2.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.3 | 4.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
1.3 | 2.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 1.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.3 | 5.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.3 | 6.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
1.3 | 1.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.3 | 5.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.3 | 3.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.3 | 3.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.3 | 1.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.3 | 3.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.3 | 5.1 | GO:0032264 | IMP salvage(GO:0032264) |
1.3 | 3.8 | GO:0015817 | histidine transport(GO:0015817) |
1.3 | 5.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.3 | 2.5 | GO:0009597 | detection of virus(GO:0009597) |
1.3 | 3.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.3 | 3.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.3 | 5.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.3 | 2.5 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.3 | 2.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.3 | 1.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.3 | 3.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.2 | 22.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.2 | 6.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.2 | 3.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.2 | 6.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.2 | 3.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.2 | 2.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.2 | 2.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
1.2 | 1.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.2 | 3.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.2 | 3.6 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.2 | 3.6 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
1.2 | 3.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.2 | 4.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.2 | 4.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.2 | 3.5 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.2 | 3.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.2 | 3.5 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.2 | 9.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.2 | 3.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.2 | 2.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.2 | 3.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.1 | 8.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.1 | 9.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.1 | 4.6 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.1 | 3.4 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
1.1 | 8.0 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
1.1 | 10.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.1 | 3.4 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.1 | 12.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
1.1 | 11.3 | GO:0007379 | segment specification(GO:0007379) |
1.1 | 3.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.1 | 1.1 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
1.1 | 15.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.1 | 2.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.1 | 2.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.1 | 10.1 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
1.1 | 5.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.1 | 2.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.1 | 2.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.1 | 33.2 | GO:0006953 | acute-phase response(GO:0006953) |
1.1 | 5.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.1 | 3.3 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.1 | 5.5 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
1.1 | 1.1 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
1.1 | 1.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
1.1 | 2.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.1 | 5.4 | GO:0006007 | glucose catabolic process(GO:0006007) |
1.1 | 2.2 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
1.1 | 4.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
1.1 | 7.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.1 | 4.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 3.2 | GO:0035973 | aggrephagy(GO:0035973) |
1.1 | 3.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.1 | 3.2 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
1.1 | 3.2 | GO:0007097 | nuclear migration(GO:0007097) |
1.1 | 6.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.1 | 4.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
1.1 | 10.7 | GO:2000194 | regulation of female gonad development(GO:2000194) |
1.1 | 3.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.1 | 4.3 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
1.1 | 3.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.1 | 23.4 | GO:0006301 | postreplication repair(GO:0006301) |
1.1 | 3.2 | GO:0015819 | lysine transport(GO:0015819) |
1.1 | 4.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.1 | 5.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.1 | 5.3 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
1.0 | 1.0 | GO:0006734 | NADH metabolic process(GO:0006734) |
1.0 | 5.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.0 | 2.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.0 | 1.0 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
1.0 | 2.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.0 | 3.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.0 | 3.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.0 | 3.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.0 | 2.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.0 | 4.1 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
1.0 | 18.5 | GO:0030488 | tRNA methylation(GO:0030488) |
1.0 | 3.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.0 | 3.1 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.0 | 5.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
1.0 | 2.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.0 | 10.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.0 | 2.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.0 | 1.0 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.0 | 1.0 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
1.0 | 2.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.0 | 4.0 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.0 | 15.0 | GO:0014850 | response to muscle activity(GO:0014850) |
1.0 | 1.0 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
1.0 | 5.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.0 | 7.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.0 | 2.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.0 | 2.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.0 | 3.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.0 | 1.0 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.0 | 5.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.0 | 1.9 | GO:0000050 | urea cycle(GO:0000050) |
1.0 | 1.0 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
1.0 | 5.8 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.0 | 25.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
1.0 | 2.9 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
1.0 | 10.7 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
1.0 | 4.8 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.0 | 16.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
1.0 | 6.7 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
1.0 | 2.9 | GO:0002432 | granuloma formation(GO:0002432) |
1.0 | 6.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
1.0 | 2.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.0 | 1.0 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.0 | 3.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.0 | 1.9 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
1.0 | 2.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.0 | 2.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.0 | 10.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
1.0 | 6.7 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
1.0 | 2.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.9 | 0.9 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.9 | 1.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.9 | 1.9 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.9 | 3.8 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.9 | 0.9 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.9 | 2.8 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.9 | 6.6 | GO:0014823 | response to activity(GO:0014823) |
0.9 | 0.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.9 | 1.9 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.9 | 0.9 | GO:0071374 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
0.9 | 32.8 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.9 | 7.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.9 | 0.9 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.9 | 1.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.9 | 1.9 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.9 | 11.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.9 | 1.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.9 | 3.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.9 | 3.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.9 | 2.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.9 | 22.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.9 | 3.7 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.9 | 11.9 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.9 | 6.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.9 | 8.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.9 | 0.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.9 | 7.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.9 | 2.7 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.9 | 1.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.9 | 0.9 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.9 | 6.3 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.9 | 4.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.9 | 1.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.9 | 1.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.9 | 5.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.9 | 0.9 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.9 | 5.3 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.9 | 8.9 | GO:0006828 | manganese ion transport(GO:0006828) |
0.9 | 1.8 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.9 | 1.8 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.9 | 11.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.9 | 2.6 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.9 | 0.9 | GO:0070627 | ferrous iron import(GO:0070627) |
0.9 | 6.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.9 | 3.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.9 | 1.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.9 | 4.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.9 | 7.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.9 | 5.2 | GO:0015871 | choline transport(GO:0015871) |
0.9 | 2.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.9 | 14.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.9 | 2.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 0.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.9 | 0.9 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.9 | 13.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.9 | 3.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.9 | 4.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.9 | 1.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.9 | 0.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.9 | 1.7 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.9 | 1.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.9 | 6.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.9 | 1.7 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.8 | 2.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.8 | 1.7 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.8 | 3.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.8 | 2.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.8 | 8.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.8 | 0.8 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.8 | 8.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.8 | 0.8 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.8 | 4.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.8 | 14.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.8 | 4.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.8 | 4.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.8 | 1.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.8 | 2.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.8 | 10.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 4.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.8 | 4.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.8 | 0.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.8 | 14.8 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.8 | 12.3 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
0.8 | 3.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.8 | 10.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.8 | 2.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.8 | 3.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.8 | 2.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 1.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.8 | 3.2 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
0.8 | 2.4 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.8 | 1.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.8 | 0.8 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.8 | 2.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.8 | 1.6 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.8 | 4.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.8 | 2.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.8 | 1.6 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.8 | 3.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.8 | 3.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.8 | 6.3 | GO:0000338 | protein deneddylation(GO:0000338) |
0.8 | 2.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.8 | 3.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.8 | 1.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.8 | 1.6 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.8 | 2.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.8 | 4.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.8 | 6.3 | GO:0097286 | iron ion import(GO:0097286) |
0.8 | 3.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.8 | 2.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 | 1.6 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.8 | 0.8 | GO:0015677 | copper ion import(GO:0015677) |
0.8 | 6.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.8 | 2.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.8 | 1.5 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.8 | 0.8 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.8 | 3.8 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.8 | 3.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.8 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.8 | 3.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.8 | 1.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.8 | 4.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.8 | 1.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.8 | 0.8 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.8 | 0.8 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.7 | 0.7 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.7 | 8.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.7 | 0.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.7 | 4.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.7 | 2.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.7 | 1.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.7 | 0.7 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.7 | 2.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 2.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.7 | 1.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.7 | 3.7 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.7 | 3.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.7 | 2.2 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.7 | 1.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.7 | 8.0 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.7 | 2.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.7 | 4.4 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.7 | 4.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.7 | 1.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.7 | 4.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.7 | 2.9 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.7 | 1.4 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.7 | 4.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.7 | 0.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.7 | 5.7 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.7 | 0.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.7 | 1.4 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.7 | 1.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.7 | 0.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.7 | 1.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.7 | 7.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.7 | 1.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.7 | 2.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.7 | 2.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.7 | 1.4 | GO:0015809 | arginine transport(GO:0015809) |
0.7 | 3.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.7 | 1.4 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.7 | 0.7 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.7 | 2.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.7 | 3.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.7 | 16.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.7 | 3.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.7 | 6.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.7 | 1.4 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.7 | 1.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.7 | 6.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.7 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.7 | 16.4 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.7 | 2.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.7 | 1.4 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.7 | 1.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.7 | 3.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.7 | 0.7 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.7 | 1.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.7 | 1.3 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.7 | 1.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.7 | 0.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.7 | 5.3 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.7 | 1.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.7 | 2.7 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.7 | 0.7 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.7 | 1.3 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.7 | 2.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.7 | 2.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.7 | 3.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.7 | 0.7 | GO:0042701 | progesterone secretion(GO:0042701) |
0.7 | 2.0 | GO:0015744 | succinate transport(GO:0015744) |
0.7 | 1.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 4.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.7 | 1.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.7 | 6.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.7 | 5.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.7 | 2.6 | GO:0015886 | heme transport(GO:0015886) |
0.7 | 3.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.6 | 0.6 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.6 | 2.6 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.6 | 1.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 5.2 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.6 | 5.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.6 | 0.6 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.6 | 1.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.6 | 1.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.6 | 5.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.6 | 3.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.6 | 0.6 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.6 | 7.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.6 | 1.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.6 | 17.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.6 | 1.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.6 | 0.6 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.6 | 2.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.6 | 2.5 | GO:0005979 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) |
0.6 | 1.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.6 | 1.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 3.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.6 | 1.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.6 | 0.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.6 | 3.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.6 | 1.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 3.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.6 | 13.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.6 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.6 | 6.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.6 | 1.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.6 | 4.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.6 | 13.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.6 | 1.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.6 | 5.6 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.6 | 1.9 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
0.6 | 0.6 | GO:0032898 | neurotrophin production(GO:0032898) |
0.6 | 3.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.6 | 0.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 | 4.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.6 | 3.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.6 | 0.6 | GO:0060174 | limb bud formation(GO:0060174) |
0.6 | 0.6 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.6 | 3.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.6 | 2.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 0.6 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 0.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 | 2.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.6 | 1.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 0.6 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.6 | 4.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.6 | 1.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.6 | 1.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.6 | 0.6 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.6 | 1.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 6.0 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.6 | 0.6 | GO:0070339 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.6 | 3.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 8.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.6 | 0.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 0.6 | GO:0007619 | courtship behavior(GO:0007619) |
0.6 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.6 | 8.9 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.6 | 3.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.6 | 0.6 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.6 | 4.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.6 | 2.4 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.6 | 1.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 1.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 2.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 2.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.6 | 4.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.6 | 1.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.6 | 4.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.6 | 5.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.6 | 1.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.6 | 4.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.6 | 4.7 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.6 | 0.6 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.6 | 1.7 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.6 | 4.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.6 | 1.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 1.7 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.6 | 1.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.6 | 1.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 3.5 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.6 | 1.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 1.7 | GO:0060023 | soft palate development(GO:0060023) |
0.6 | 1.2 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.6 | 1.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.6 | 1.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.6 | 2.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.6 | 0.6 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.6 | 0.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.6 | 3.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.6 | 4.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.6 | 1.7 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.6 | 1.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.6 | 5.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.6 | 1.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.6 | 0.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.6 | 3.9 | GO:0035878 | nail development(GO:0035878) |
0.6 | 6.2 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.6 | 1.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 3.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.6 | 0.6 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.6 | 1.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.6 | 0.6 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.6 | 0.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.6 | 1.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.6 | 2.8 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.6 | 0.6 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.6 | 2.8 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.6 | 2.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.6 | 1.7 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.6 | 2.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.6 | 1.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.5 | 0.5 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 1.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.5 | 0.5 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.5 | 4.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.5 | 2.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.5 | 1.6 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.5 | 1.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.5 | 2.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 1.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.5 | 2.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 3.8 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.5 | 1.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.5 | 1.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.5 | 4.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.5 | 1.1 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.5 | 4.8 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.5 | 1.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.5 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.5 | 1.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.5 | 3.2 | GO:0006833 | water transport(GO:0006833) |
0.5 | 4.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.5 | 2.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 1.1 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.5 | 4.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.5 | 1.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 3.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.5 | 1.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 0.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.5 | 1.6 | GO:0015791 | polyol transport(GO:0015791) |
0.5 | 4.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 1.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 0.5 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.5 | 2.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.5 | 3.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 3.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.5 | 4.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.5 | 4.7 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.5 | 4.7 | GO:0031100 | organ regeneration(GO:0031100) |
0.5 | 1.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.5 | 1.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.5 | 1.6 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.5 | 2.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 3.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 1.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.5 | 1.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.5 | 1.0 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.5 | 1.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.5 | 2.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.5 | 2.1 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.5 | 0.5 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.5 | 8.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.5 | 1.0 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.5 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 4.5 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.5 | 1.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.5 | 2.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.5 | 3.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.5 | 3.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.5 | 8.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.5 | 24.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.5 | 1.5 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.5 | 2.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 33.2 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.5 | 1.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.5 | 2.5 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.5 | 1.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.5 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 0.5 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.5 | 1.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 1.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 19.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.5 | 0.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.5 | 1.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.5 | 2.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.5 | 1.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.5 | 6.4 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.5 | 1.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.5 | 2.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.5 | 6.8 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.5 | 1.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 0.5 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 2.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 1.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.5 | 1.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.5 | 6.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 8.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.5 | 1.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 3.8 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.5 | 1.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.5 | 2.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 5.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.5 | 2.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.5 | 1.4 | GO:0060613 | fat pad development(GO:0060613) |
0.5 | 0.9 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.5 | 3.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.5 | 1.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 | 1.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.5 | 3.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.5 | 2.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.5 | 9.9 | GO:0048240 | sperm capacitation(GO:0048240) |
0.5 | 0.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.5 | 0.9 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.5 | 0.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.5 | 0.9 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.5 | 1.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 1.4 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 0.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 1.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.5 | 4.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.5 | 9.3 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.5 | 0.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.5 | 0.9 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.5 | 33.1 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.5 | 1.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 0.5 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.5 | 1.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 4.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.5 | 1.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.5 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 1.4 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.5 | 0.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.5 | 7.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.5 | 2.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.5 | 0.5 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.5 | 3.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.5 | 0.5 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.5 | 4.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.5 | 2.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.5 | 0.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.5 | 0.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.5 | 1.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.5 | 1.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.5 | 1.8 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 1.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 1.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.5 | 3.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.5 | 3.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 0.9 | GO:0009838 | abscission(GO:0009838) |
0.4 | 10.8 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.4 | 2.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.4 | 4.9 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.4 | 1.8 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.4 | 2.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.4 | 0.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.4 | 2.7 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.4 | 3.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.4 | 1.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 2.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.4 | 0.4 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.4 | 3.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 2.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.4 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.4 | 4.9 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.4 | 2.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.4 | 1.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 1.8 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.4 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 4.4 | GO:0032608 | interferon-beta production(GO:0032608) |
0.4 | 4.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.4 | 0.9 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.4 | 1.3 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.4 | 1.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.4 | 0.9 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.4 | 1.3 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
0.4 | 2.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 10.1 | GO:0019319 | hexose biosynthetic process(GO:0019319) monosaccharide biosynthetic process(GO:0046364) |
0.4 | 4.4 | GO:0009648 | photoperiodism(GO:0009648) |
0.4 | 1.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 3.5 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.4 | 1.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.4 | 0.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 0.9 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.4 | 0.4 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.4 | 3.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.4 | 2.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.4 | 2.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.4 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.4 | 1.7 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.4 | 0.4 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.4 | 1.3 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 1.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 0.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 1.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 1.3 | GO:0060068 | vagina development(GO:0060068) |
0.4 | 0.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.4 | 0.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 1.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 1.3 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.4 | 0.9 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.4 | 0.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.4 | 0.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 1.3 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 3.0 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.4 | 15.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.4 | 1.7 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.4 | 0.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.4 | 0.8 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 0.8 | GO:0035799 | ureter maturation(GO:0035799) |
0.4 | 4.2 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.4 | 0.8 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 2.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.4 | 0.4 | GO:2000064 | regulation of cortisol biosynthetic process(GO:2000064) |
0.4 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 0.8 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.4 | 2.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 0.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.4 | 0.8 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 1.6 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.4 | 2.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.4 | 2.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.4 | 1.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.4 | 0.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 0.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 1.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.4 | 0.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 1.6 | GO:0072537 | fibroblast activation(GO:0072537) |
0.4 | 0.8 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.4 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 2.4 | GO:0010712 | regulation of collagen metabolic process(GO:0010712) |
0.4 | 4.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.4 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 0.8 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.4 | 3.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 1.6 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.4 | 1.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.4 | 1.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.4 | 15.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.4 | 4.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.4 | 1.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.4 | 3.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.4 | 2.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 0.4 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.4 | 51.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.4 | 0.4 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.4 | 2.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 3.6 | GO:0032418 | lysosome localization(GO:0032418) |
0.4 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 7.5 | GO:0030168 | platelet activation(GO:0030168) |
0.4 | 0.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.4 | 2.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 2.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.4 | 1.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.4 | 2.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 10.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.4 | 1.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.4 | 0.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.4 | 0.4 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 0.8 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 1.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 0.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.4 | 4.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.4 | 3.9 | GO:0002347 | response to tumor cell(GO:0002347) |
0.4 | 7.3 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.4 | 1.9 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.4 | 0.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.4 | 0.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 2.3 | GO:0007135 | meiosis II(GO:0007135) |
0.4 | 3.1 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.4 | 1.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.4 | 0.4 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.4 | 1.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 0.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 0.4 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.4 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 3.8 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.4 | 0.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 1.9 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 5.6 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.4 | 0.8 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.4 | 2.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 1.1 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.4 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 0.7 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.4 | 3.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 1.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 1.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.4 | 1.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 2.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.4 | 1.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 0.4 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.4 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 1.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.4 | 4.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 1.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.4 | 0.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.4 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.5 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.4 | 6.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 1.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 2.6 | GO:0050779 | RNA destabilization(GO:0050779) |
0.4 | 2.6 | GO:0070542 | response to fatty acid(GO:0070542) |
0.4 | 1.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.4 | 2.2 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.4 | 2.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 0.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.4 | 7.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.4 | 1.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.4 | 0.7 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.4 | 1.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 2.2 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.4 | 0.7 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 1.4 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.4 | 6.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.4 | 8.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 2.5 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.4 | 0.4 | GO:0032079 | positive regulation of deoxyribonuclease activity(GO:0032077) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.4 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 2.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.4 | 1.8 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.4 | 2.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 1.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.4 | 3.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 2.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.4 | 1.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.4 | 6.7 | GO:1901998 | toxin transport(GO:1901998) |
0.4 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.3 | 1.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 0.7 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.3 | 3.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 0.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 4.5 | GO:0006096 | glycolytic process(GO:0006096) |
0.3 | 7.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 2.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 0.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.3 | 4.9 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.3 | 1.0 | GO:0045006 | DNA deamination(GO:0045006) |
0.3 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.7 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 0.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 3.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 1.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.3 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 2.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 1.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.3 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 7.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 0.3 | GO:0007100 | mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 0.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 2.1 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.3 | 1.7 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.3 | 0.3 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.3 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 2.0 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 3.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.3 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 2.7 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.3 | 2.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.3 | 1.7 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 2.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 0.7 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.3 | 0.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.3 | 25.1 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.3 | 6.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 1.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 6.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.3 | 0.3 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.3 | 1.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 2.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.3 | 2.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 1.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.3 | 1.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.3 | 2.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 1.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.7 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.3 | 2.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 1.3 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.3 | 1.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 1.3 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.3 | 0.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 0.6 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 0.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 8.1 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.3 | 1.6 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.3 | 1.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 1.6 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.3 | 2.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 1.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.3 | 1.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.3 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 1.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 1.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.3 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 1.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 2.5 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.3 | 0.3 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.3 | 1.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.3 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.3 | 0.3 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.3 | 1.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.3 | 2.8 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.3 | 0.3 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.3 | 0.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 0.3 | GO:0036491 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.3 | 1.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.3 | 3.7 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.3 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.3 | 0.6 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.3 | 0.3 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.3 | 0.3 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.3 | 0.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.3 | 1.2 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 1.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 0.9 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.3 | 2.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.3 | 0.9 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 6.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 0.3 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.3 | 3.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.3 | 1.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.3 | 0.9 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.3 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
0.3 | 3.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.3 | 5.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.3 | 0.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.3 | 14.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 5.9 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.3 | 0.3 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 17.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 0.6 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.3 | 4.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 1.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 0.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 0.6 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.9 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 1.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.3 | 2.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 1.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 0.3 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.3 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 6.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.3 | 0.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 2.8 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.3 | 5.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 0.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 0.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 0.3 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.3 | 0.6 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 0.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.3 | 0.3 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.3 | 4.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.3 | 1.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 0.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.3 | 0.6 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 0.8 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.3 | 10.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 2.5 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.3 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 0.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 2.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.3 | 0.3 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.3 | 1.7 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.3 | 0.3 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 1.7 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 3.0 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.3 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 1.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 1.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 26.4 | GO:0006457 | protein folding(GO:0006457) |
0.3 | 0.3 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.3 | 0.8 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 1.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 0.3 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.3 | 2.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.3 | 1.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 6.2 | GO:0046849 | bone remodeling(GO:0046849) |
0.3 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.3 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.3 | 5.1 | GO:0044839 | cell cycle G2/M phase transition(GO:0044839) |
0.3 | 0.5 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.3 | 3.5 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.3 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.3 | 0.8 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.3 | 0.3 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 0.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 1.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 0.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 4.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 0.3 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.3 | 0.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 0.8 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 0.3 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.3 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.3 | 2.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 1.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 1.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.3 | 3.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 4.4 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.3 | 0.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 0.8 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.3 | 0.3 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.3 | 3.6 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.3 | 0.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.3 | 0.5 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.3 | 1.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 0.5 | GO:0033280 | response to vitamin D(GO:0033280) |
0.3 | 0.3 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.3 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 1.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 0.3 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 2.0 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 2.0 | GO:0032400 | melanosome localization(GO:0032400) |
0.2 | 3.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 0.5 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 0.7 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.2 | 2.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.2 | 1.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 2.7 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 4.8 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.2 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 1.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.2 | GO:0097484 | dendrite extension(GO:0097484) |
0.2 | 0.2 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
0.2 | 0.7 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 1.7 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.2 | 0.2 | GO:0051255 | spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) |
0.2 | 0.2 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.2 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.7 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.5 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.2 | 0.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 0.9 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.2 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
0.2 | 1.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 2.5 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.5 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 0.5 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.2 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.2 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 1.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 6.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 0.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 1.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 6.9 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 1.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.9 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 1.8 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.2 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 0.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.7 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.2 | 0.2 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.2 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 2.8 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.2 | 2.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 1.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.2 | 1.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 1.3 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.2 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 1.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 4.9 | GO:0009124 | nucleoside monophosphate biosynthetic process(GO:0009124) |
0.2 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 0.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 2.3 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.2 | 0.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 2.1 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 4.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 2.1 | GO:0098534 | centriole assembly(GO:0098534) |
0.2 | 1.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 1.6 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 0.2 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.2 | 2.0 | GO:0030104 | water homeostasis(GO:0030104) |
0.2 | 1.4 | GO:0006956 | complement activation(GO:0006956) |
0.2 | 1.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.2 | 1.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.6 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.2 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) |
0.2 | 1.0 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.2 | 1.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.2 | 0.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 5.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 0.6 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 1.0 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.2 | 4.0 | GO:0006909 | phagocytosis(GO:0006909) |
0.2 | 0.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
0.2 | 1.0 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.2 | 1.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 1.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 2.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 2.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.4 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 0.2 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.2 | 3.1 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.2 | 1.2 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.2 | 3.7 | GO:0048477 | oogenesis(GO:0048477) |
0.2 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 0.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 1.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.4 | GO:0061009 | common bile duct development(GO:0061009) |
0.2 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 2.1 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 0.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.4 | GO:0019081 | viral translation(GO:0019081) |
0.2 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 1.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 1.7 | GO:0007140 | male meiosis(GO:0007140) |
0.2 | 0.7 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 3.0 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.2 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.7 | GO:0097240 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 0.4 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.2 | 0.2 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.2 | 0.2 | GO:2000831 | regulation of steroid hormone secretion(GO:2000831) |
0.2 | 0.4 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.2 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.2 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 0.5 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 0.4 | GO:0010755 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 0.2 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) serotonergic neuron axon guidance(GO:0036515) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.2 | 0.5 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.2 | 3.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 3.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.2 | GO:0003094 | glomerular filtration(GO:0003094) |
0.2 | 0.9 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 2.7 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 0.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.4 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.2 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.2 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 0.2 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) |
0.2 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.7 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 10.1 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.2 | 0.3 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.2 | 0.2 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.2 | 10.1 | GO:0006821 | chloride transport(GO:0006821) |
0.2 | 0.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 1.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.2 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 1.0 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.2 | 0.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.2 | 0.8 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.2 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.8 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.2 | 2.5 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.2 | 3.5 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 2.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.8 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.2 | 0.6 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 2.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 1.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 0.2 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.2 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.2 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.2 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 0.2 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 0.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.2 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.3 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.2 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 2.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.5 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.8 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.2 | 0.8 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.2 | 0.2 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.2 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.3 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.3 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 1.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.3 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 2.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 1.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.4 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.1 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.1 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.6 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 1.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 2.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.9 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.7 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.1 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.1 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.1 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 3.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 1.7 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 1.2 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.1 | 0.1 | GO:0009620 | response to fungus(GO:0009620) |
0.1 | 0.1 | GO:0071604 | transforming growth factor beta production(GO:0071604) |
0.1 | 0.1 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 1.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.1 | 0.3 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.4 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.4 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) cellular response to UV-A(GO:0071492) |
0.1 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 2.9 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.3 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.1 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.3 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.1 | 0.1 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.1 | 1.6 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.2 | GO:0043482 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.5 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.7 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.1 | 0.5 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 1.1 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 0.5 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 1.3 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 2.7 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.7 | GO:0019748 | secondary metabolic process(GO:0019748) |
0.1 | 0.6 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 2.2 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 2.1 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.1 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.8 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.2 | GO:0003230 | cardiac atrium development(GO:0003230) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.7 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.3 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.5 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 1.1 | GO:0048678 | response to axon injury(GO:0048678) |
0.1 | 0.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 1.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 1.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.1 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 1.3 | GO:0032147 | activation of protein kinase activity(GO:0032147) |
0.1 | 1.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) cellular response to water stimulus(GO:0071462) |
0.1 | 0.5 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 1.2 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 1.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 1.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.2 | GO:0010662 | regulation of striated muscle cell apoptotic process(GO:0010662) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 7.8 | GO:0016311 | dephosphorylation(GO:0016311) |
0.1 | 0.2 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.1 | 0.9 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.6 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 1.0 | GO:0009063 | cellular amino acid catabolic process(GO:0009063) |
0.1 | 0.1 | GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production(GO:1903555) |
0.1 | 2.1 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0007129 | synapsis(GO:0007129) |
0.1 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 1.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.3 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.1 | GO:1901658 | glycosyl compound catabolic process(GO:1901658) |
0.1 | 0.1 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 1.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.1 | GO:0032633 | interleukin-4 production(GO:0032633) |
0.1 | 0.3 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 0.3 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 1.1 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.1 | 0.3 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.2 | GO:0006644 | phospholipid metabolic process(GO:0006644) |
0.1 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.1 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.1 | GO:0019229 | regulation of vasoconstriction(GO:0019229) |
0.1 | 0.1 | GO:0060964 | regulation of gene silencing by miRNA(GO:0060964) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 11.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.8 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.9 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.1 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 1.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.1 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.1 | 0.3 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.1 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.9 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.5 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.3 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 0.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 0.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.7 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.1 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.1 | GO:0010894 | negative regulation of steroid biosynthetic process(GO:0010894) negative regulation of steroid metabolic process(GO:0045939) |
0.1 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.1 | GO:0060688 | regulation of morphogenesis of a branching structure(GO:0060688) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.2 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.2 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.1 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.1 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.1 | 0.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 2.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.2 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 1.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 1.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.6 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.2 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.0 | GO:0051029 | rRNA export from nucleus(GO:0006407) rRNA transport(GO:0051029) |
0.0 | 0.1 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 0.9 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0019068 | virion assembly(GO:0019068) |
0.0 | 0.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.0 | 0.0 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.0 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.0 | 0.3 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.0 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.1 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.0 | 0.1 | GO:2000677 | regulation of transcription regulatory region DNA binding(GO:2000677) |
0.0 | 0.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.0 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.4 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 2.2 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.0 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0098762 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.5 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.0 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.0 | 0.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.8 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.0 | GO:0071869 | response to catecholamine(GO:0071869) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.1 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.3 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.0 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.1 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.2 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0044851 | hair cycle phase(GO:0044851) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 5.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
4.8 | 14.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
4.5 | 4.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
3.9 | 11.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.6 | 21.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
3.3 | 9.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.9 | 26.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
2.5 | 10.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.5 | 2.5 | GO:0031512 | motile primary cilium(GO:0031512) |
2.5 | 14.7 | GO:0031983 | vesicle lumen(GO:0031983) |
2.3 | 9.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
2.2 | 24.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.2 | 4.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
2.1 | 12.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
2.1 | 8.2 | GO:1903349 | omegasome membrane(GO:1903349) |
2.0 | 10.2 | GO:0005579 | membrane attack complex(GO:0005579) |
2.0 | 6.1 | GO:0097513 | myosin II filament(GO:0097513) |
1.9 | 11.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.8 | 27.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.8 | 9.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.7 | 7.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.7 | 6.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.7 | 6.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.6 | 4.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.6 | 4.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.6 | 9.7 | GO:0097342 | ripoptosome(GO:0097342) |
1.6 | 16.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
1.6 | 7.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.6 | 14.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.6 | 3.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.6 | 15.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.6 | 4.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.5 | 16.9 | GO:0042627 | chylomicron(GO:0042627) |
1.5 | 6.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.5 | 5.9 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.4 | 13.0 | GO:0036128 | CatSper complex(GO:0036128) |
1.4 | 4.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.4 | 4.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.4 | 10.0 | GO:0043219 | lateral loop(GO:0043219) |
1.4 | 4.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.4 | 10.8 | GO:0045179 | apical cortex(GO:0045179) |
1.3 | 6.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.3 | 18.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.3 | 5.2 | GO:0030478 | actin cap(GO:0030478) |
1.2 | 13.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.2 | 1.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.2 | 3.7 | GO:0097443 | sorting endosome(GO:0097443) |
1.2 | 4.9 | GO:0071953 | elastic fiber(GO:0071953) |
1.2 | 8.5 | GO:0030056 | hemidesmosome(GO:0030056) |
1.1 | 3.4 | GO:0031417 | NatC complex(GO:0031417) |
1.1 | 6.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 3.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.1 | 13.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.1 | 1.1 | GO:0042585 | germinal vesicle(GO:0042585) |
1.0 | 1.0 | GO:0046930 | pore complex(GO:0046930) |
1.0 | 9.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.0 | 2.0 | GO:0031523 | Myb complex(GO:0031523) |
1.0 | 9.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.0 | 3.0 | GO:0000811 | GINS complex(GO:0000811) |
1.0 | 14.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.0 | 7.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 2.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.0 | 3.8 | GO:1990130 | Iml1 complex(GO:1990130) |
1.0 | 2.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 3.8 | GO:0016342 | catenin complex(GO:0016342) |
0.9 | 3.7 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.9 | 3.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.9 | 2.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.9 | 2.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.9 | 7.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.9 | 58.0 | GO:0042641 | actomyosin(GO:0042641) |
0.9 | 4.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.9 | 4.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.9 | 5.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.9 | 4.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.9 | 3.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.9 | 1.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.8 | 2.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 2.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.8 | 1.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.8 | 0.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.8 | 23.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.8 | 5.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.8 | 14.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.8 | 4.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 2.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 4.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.8 | 7.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 2.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 6.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.8 | 3.9 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.8 | 7.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.8 | 2.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.8 | 6.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.8 | 9.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.8 | 3.8 | GO:0071437 | invadopodium(GO:0071437) |
0.8 | 2.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.8 | 17.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.7 | 34.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.7 | 2.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.7 | 2.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.7 | 13.3 | GO:0045120 | pronucleus(GO:0045120) |
0.7 | 37.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.7 | 2.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 10.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.7 | 1.5 | GO:0098576 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.7 | 1.5 | GO:0032432 | actin filament bundle(GO:0032432) |
0.7 | 30.1 | GO:0016459 | myosin complex(GO:0016459) |
0.7 | 21.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.7 | 4.9 | GO:0030057 | desmosome(GO:0030057) |
0.7 | 9.9 | GO:0000145 | exocyst(GO:0000145) |
0.7 | 6.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.7 | 10.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.7 | 2.8 | GO:0071203 | WASH complex(GO:0071203) |
0.7 | 2.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 21.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.7 | 1.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.7 | 69.5 | GO:0001726 | ruffle(GO:0001726) |
0.7 | 2.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.7 | 5.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.7 | 2.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.6 | 13.6 | GO:0008305 | integrin complex(GO:0008305) |
0.6 | 2.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 1.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.6 | 0.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 12.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.6 | 1.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 3.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 8.8 | GO:0043196 | varicosity(GO:0043196) |
0.6 | 5.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.6 | 1.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 3.0 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 1.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 9.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.6 | 4.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.6 | 6.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.6 | 0.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.6 | 10.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.6 | 0.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 3.5 | GO:0099738 | cell cortex region(GO:0099738) |
0.6 | 1.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 0.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.6 | 38.8 | GO:0030496 | midbody(GO:0030496) |
0.6 | 5.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.6 | 13.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.6 | 12.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.6 | 2.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.6 | 5.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.6 | 1.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 5.0 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.6 | 0.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.6 | 7.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 3.3 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 3.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.5 | 1.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.5 | 25.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 3.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.5 | 2.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.5 | 23.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 5.3 | GO:0030118 | clathrin coat(GO:0030118) |
0.5 | 2.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 1.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.5 | 0.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.5 | 1.0 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 1.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.5 | 7.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 4.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.5 | 1.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.5 | 2.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.5 | 6.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.5 | 1.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 1.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 19.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.5 | 1.0 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 6.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.5 | 14.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.5 | 6.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.5 | 28.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 20.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.5 | 0.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 4.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.5 | 11.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 3.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 1.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.5 | 1.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 95.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.5 | 1.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 4.3 | GO:0010369 | chromocenter(GO:0010369) |
0.5 | 2.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 9.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.5 | 1.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 2.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 1.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 1.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 1.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 0.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 2.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 1.4 | GO:1990745 | EARP complex(GO:1990745) |
0.5 | 1.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 0.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.5 | 6.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.5 | 2.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 14.3 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 3.7 | GO:0032797 | SMN complex(GO:0032797) |
0.5 | 7.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.5 | 1.8 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 2.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.5 | 4.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 4.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 6.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.4 | 3.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 4.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 0.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.4 | 23.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 0.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 11.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.4 | 3.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 9.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 1.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.3 | GO:0043218 | compact myelin(GO:0043218) |
0.4 | 3.4 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 1.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 1.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 1.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 1.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 1.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 1.3 | GO:0030425 | dendrite(GO:0030425) |
0.4 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 3.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 2.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 24.9 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.4 | 9.5 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.4 | 2.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 0.8 | GO:0005818 | aster(GO:0005818) |
0.4 | 6.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.4 | 19.5 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 43.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.4 | 2.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 3.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 1.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 2.0 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.4 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.4 | 30.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 0.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 1.6 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 2.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 77.4 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.4 | 14.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 3.2 | GO:0000791 | euchromatin(GO:0000791) |
0.4 | 2.3 | GO:0000801 | central element(GO:0000801) |
0.4 | 7.4 | GO:0005903 | brush border(GO:0005903) |
0.4 | 0.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.4 | 5.4 | GO:0005844 | polysome(GO:0005844) |
0.4 | 2.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 1.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 6.6 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 10.8 | GO:0005902 | microvillus(GO:0005902) |
0.4 | 3.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.4 | 1.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 6.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 24.6 | GO:0005814 | centriole(GO:0005814) |
0.4 | 0.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.4 | 2.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 3.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.4 | 6.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 17.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 3.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 2.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 0.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 14.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 1.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 12.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.4 | 0.4 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 5.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 8.2 | GO:0005776 | autophagosome(GO:0005776) |
0.4 | 3.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 1.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 1.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 38.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 0.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 18.1 | GO:0012505 | endomembrane system(GO:0012505) |
0.3 | 5.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 2.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 10.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 8.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 1.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 0.7 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.3 | 1.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.3 | 15.0 | GO:0045177 | apical part of cell(GO:0045177) |
0.3 | 559.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.3 | 1.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 9.2 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 1.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 0.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 1.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 1.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 2.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 3.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 6.7 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 2.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 18.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.3 | 1.9 | GO:0002102 | podosome(GO:0002102) |
0.3 | 20.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 4.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 0.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 2.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 3.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 1.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 5.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 0.3 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.3 | 1.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 2.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 0.9 | GO:0005712 | chiasma(GO:0005712) |
0.3 | 40.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 1.7 | GO:0005657 | replication fork(GO:0005657) |
0.3 | 3.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 1.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 8.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 4.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 2.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.3 | 5.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.3 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.3 | 3.3 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.3 | 19.6 | GO:0005769 | early endosome(GO:0005769) |
0.3 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 3.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 18.6 | GO:0019867 | outer membrane(GO:0019867) |
0.3 | 2.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.3 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 3.7 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 9.2 | GO:0005938 | cell cortex(GO:0005938) |
0.3 | 0.5 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 3.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 0.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 3.6 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.3 | 1.8 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 23.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 1.5 | GO:0000785 | chromatin(GO:0000785) |
0.3 | 1.3 | GO:0000243 | commitment complex(GO:0000243) |
0.3 | 4.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.3 | 0.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 7.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 2.5 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.5 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 4.6 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 1.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 7.3 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.2 | 0.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 7.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 148.8 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 0.2 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.2 | 3.5 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.2 | 0.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 0.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 1.8 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 0.9 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.2 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 1.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 45.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 1.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 1.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.2 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 143.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) HULC complex(GO:0033503) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 8.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 1.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 40.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 153.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 2.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 1.5 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 87.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.3 | GO:0031514 | motile cilium(GO:0031514) |
0.2 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 1.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 16.4 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 2.4 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 1.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.1 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 66.7 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 1.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 8.4 | GO:0099513 | supramolecular fiber(GO:0099512) polymeric cytoskeletal fiber(GO:0099513) |
0.1 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 222.4 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 0.1 | GO:0031090 | organelle membrane(GO:0031090) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 53.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.3 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 173.7 | GO:0016020 | membrane(GO:0016020) |
0.1 | 6.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.1 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 18.7 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.0 | GO:0071944 | cell periphery(GO:0071944) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 16.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
4.8 | 14.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
4.4 | 13.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
4.4 | 13.3 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
4.3 | 12.9 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
3.5 | 14.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
3.5 | 10.5 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
3.2 | 25.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
3.1 | 9.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
3.1 | 12.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
3.0 | 9.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
2.8 | 8.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.7 | 8.0 | GO:0019862 | IgA binding(GO:0019862) |
2.7 | 24.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.7 | 15.9 | GO:0030274 | LIM domain binding(GO:0030274) |
2.6 | 7.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
2.4 | 7.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.3 | 6.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.3 | 6.9 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
2.3 | 11.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.2 | 6.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
2.2 | 2.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.1 | 18.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.1 | 8.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
2.1 | 2.1 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
2.0 | 6.1 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
2.0 | 6.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.0 | 6.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
2.0 | 22.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
2.0 | 11.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
2.0 | 7.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.9 | 5.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.9 | 11.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.9 | 5.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.9 | 7.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.9 | 1.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.8 | 5.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.7 | 3.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
1.7 | 1.7 | GO:0030523 | S-acetyltransferase activity(GO:0016418) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
1.7 | 3.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.7 | 1.7 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
1.7 | 5.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.6 | 1.6 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
1.6 | 4.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.6 | 1.6 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
1.6 | 11.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.6 | 11.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.6 | 7.9 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
1.6 | 6.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.6 | 4.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.6 | 9.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.6 | 14.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.5 | 6.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.5 | 7.7 | GO:0002054 | nucleobase binding(GO:0002054) |
1.5 | 4.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.5 | 3.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.5 | 7.5 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.5 | 4.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.5 | 4.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.5 | 4.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.5 | 4.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.4 | 15.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.4 | 5.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.4 | 5.7 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.4 | 5.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.3 | 120.6 | GO:0005178 | integrin binding(GO:0005178) |
1.3 | 1.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.3 | 4.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.3 | 9.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.3 | 14.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.3 | 7.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.3 | 7.8 | GO:0008199 | ferric iron binding(GO:0008199) |
1.3 | 5.2 | GO:0043426 | MRF binding(GO:0043426) |
1.3 | 21.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.3 | 6.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.3 | 5.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.3 | 6.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.3 | 3.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.3 | 6.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.3 | 1.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.2 | 13.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.2 | 4.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.2 | 1.2 | GO:0032190 | acrosin binding(GO:0032190) |
1.2 | 4.7 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.2 | 1.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
1.2 | 4.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 3.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.2 | 36.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.2 | 20.8 | GO:0071949 | FAD binding(GO:0071949) |
1.1 | 3.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 4.6 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.1 | 4.5 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.1 | 5.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.1 | 6.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
1.1 | 2.2 | GO:0070538 | oleic acid binding(GO:0070538) |
1.1 | 3.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.1 | 3.3 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.1 | 1.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.1 | 7.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.1 | 3.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.1 | 5.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.1 | 2.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.1 | 7.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.1 | 3.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.1 | 16.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.1 | 7.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.1 | 14.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.1 | 13.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.1 | 3.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.1 | 5.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.0 | 3.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.0 | 9.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.0 | 10.4 | GO:0019841 | retinol binding(GO:0019841) |
1.0 | 9.3 | GO:0015197 | peptide transporter activity(GO:0015197) |
1.0 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.0 | 3.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 3.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.0 | 3.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.0 | 7.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.0 | 28.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.0 | 4.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.0 | 3.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.0 | 4.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.0 | 6.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.0 | 4.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.0 | 8.9 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
1.0 | 3.9 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
1.0 | 3.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.0 | 16.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.0 | 6.8 | GO:0017166 | vinculin binding(GO:0017166) |
1.0 | 7.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.0 | 10.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.0 | 2.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.0 | 3.8 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
1.0 | 2.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.9 | 11.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.9 | 12.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.9 | 4.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.9 | 1.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.9 | 2.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.9 | 1.9 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.9 | 0.9 | GO:0001846 | opsonin binding(GO:0001846) |
0.9 | 7.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.9 | 1.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.9 | 6.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.9 | 2.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.9 | 17.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.9 | 14.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.9 | 15.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.9 | 1.8 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.9 | 13.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.9 | 4.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.9 | 2.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.9 | 4.4 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.9 | 27.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.9 | 2.6 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.9 | 3.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.9 | 3.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.9 | 3.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.9 | 4.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.9 | 19.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.9 | 1.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.9 | 4.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.8 | 2.5 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.8 | 2.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.8 | 2.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 1.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 0.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.8 | 1.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 3.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.8 | 3.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.8 | 2.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 11.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.8 | 14.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.8 | 3.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.8 | 4.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.8 | 3.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.8 | 1.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.8 | 6.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.8 | 3.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.8 | 2.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.8 | 3.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.8 | 4.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.8 | 3.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.8 | 1.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.8 | 4.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 3.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.8 | 7.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 2.4 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.8 | 0.8 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.8 | 2.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.8 | 2.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.8 | 0.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.8 | 3.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.8 | 30.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.8 | 3.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.8 | 5.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.8 | 2.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 3.1 | GO:0008430 | selenium binding(GO:0008430) |
0.8 | 87.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.8 | 15.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.8 | 4.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 1.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.8 | 9.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.8 | 5.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.8 | 3.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.8 | 2.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.8 | 0.8 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.8 | 19.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 2.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.7 | 5.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 1.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.7 | 1.5 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.7 | 10.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.7 | 14.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.7 | 2.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.7 | 2.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.7 | 4.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.7 | 2.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.7 | 2.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.7 | 0.7 | GO:0019213 | deacetylase activity(GO:0019213) |
0.7 | 7.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.7 | 11.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.7 | 3.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.7 | 2.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.7 | 8.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.7 | 35.8 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.7 | 3.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.7 | 1.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.7 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.7 | 19.9 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.7 | 5.0 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.7 | 0.7 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.7 | 6.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.7 | 1.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.7 | 4.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.7 | 2.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.7 | 1.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.7 | 15.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.7 | 3.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.7 | 6.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.7 | 2.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.7 | 2.1 | GO:0071253 | connexin binding(GO:0071253) |
0.7 | 19.8 | GO:0042805 | actinin binding(GO:0042805) |
0.7 | 2.0 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 2.0 | GO:0089720 | caspase binding(GO:0089720) |
0.7 | 5.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 0.7 | GO:0035276 | ethanol binding(GO:0035276) |
0.7 | 2.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.7 | 2.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.7 | 4.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.7 | 12.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.7 | 3.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.7 | 35.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.7 | 2.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.7 | 2.0 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.7 | 5.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.7 | 2.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 4.0 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.7 | 2.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.7 | 0.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 4.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.7 | 3.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.7 | 1.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.7 | 5.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.7 | 6.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 2.6 | GO:0009374 | biotin binding(GO:0009374) |
0.6 | 1.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.6 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.6 | 2.5 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.6 | 4.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 1.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 4.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.6 | 2.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 3.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.6 | 3.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.6 | 3.7 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 2.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 1.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 6.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.6 | 3.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.6 | 2.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 2.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.6 | 8.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.6 | 3.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.6 | 11.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.6 | 4.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.6 | 2.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 2.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 4.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.6 | 2.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.6 | 3.0 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 3.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.6 | 2.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.6 | 52.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.6 | 2.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.6 | 11.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 8.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.6 | 1.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 51.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.6 | 10.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.6 | 4.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 1.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 2.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.6 | 2.9 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 7.5 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 3.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.6 | 2.9 | GO:0035671 | enone reductase activity(GO:0035671) |
0.6 | 5.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 0.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
0.6 | 1.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 1.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 4.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.6 | 2.3 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 5.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.6 | 1.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.6 | 0.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.6 | 3.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.6 | 8.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.6 | 3.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.6 | 1.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.6 | 1.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.6 | 8.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.6 | 2.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 1.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 4.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.5 | 1.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 3.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 2.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 1.1 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 8.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.5 | 4.8 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 2.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.5 | 4.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.5 | 16.9 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.5 | 4.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.5 | 1.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 2.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.5 | 2.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.5 | 3.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 4.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 3.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 1.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 2.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 32.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.5 | 2.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.5 | 3.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 14.8 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 12.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 2.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 1.5 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.5 | 1.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.5 | 13.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.5 | 0.5 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.5 | 1.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 1.5 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.5 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 6.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 2.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.5 | 1.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 9.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 1.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 1.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.5 | 26.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.5 | 1.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 6.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.5 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.5 | 1.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 1.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.5 | 8.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 3.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.5 | 5.3 | GO:0048038 | quinone binding(GO:0048038) |
0.5 | 8.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 9.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.5 | 0.9 | GO:0016531 | copper chaperone activity(GO:0016531) superoxide dismutase copper chaperone activity(GO:0016532) |
0.5 | 4.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.5 | 2.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.5 | 1.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 0.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.5 | 25.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.5 | 1.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.5 | 4.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 1.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.5 | 1.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.5 | 0.5 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.5 | 1.8 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 2.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 0.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 3.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 23.7 | GO:0019003 | GDP binding(GO:0019003) |
0.5 | 2.7 | GO:0010181 | FMN binding(GO:0010181) |
0.5 | 0.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 2.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.5 | 1.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 2.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 2.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 2.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 1.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 0.9 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.4 | 1.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 1.3 | GO:0097617 | annealing activity(GO:0097617) |
0.4 | 0.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 9.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.4 | 4.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 1.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 1.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 9.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.4 | 4.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 2.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.4 | 1.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.4 | 1.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 7.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 9.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 1.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.4 | 2.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.4 | 0.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.4 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 0.8 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 1.2 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.4 | 16.6 | GO:0005518 | collagen binding(GO:0005518) |
0.4 | 1.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 11.6 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.4 | 1.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 2.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 1.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 3.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.4 | 2.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 2.9 | GO:0000150 | recombinase activity(GO:0000150) |
0.4 | 1.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 2.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 1.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 2.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 1.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 81.0 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.4 | 4.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 7.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 2.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.4 | 4.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 4.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.4 | 6.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.4 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.4 | 0.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.4 | 1.6 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.4 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 2.7 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.4 | 1.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 2.7 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 1.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 1.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.4 | 0.8 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.4 | 0.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 14.1 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.4 | 2.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 1.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 6.4 | GO:0050661 | NADP binding(GO:0050661) |
0.4 | 0.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 2.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.4 | 11.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.4 | 0.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 4.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 6.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 1.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 8.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.4 | 1.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 1.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 12.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.4 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 1.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 1.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 16.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 0.7 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 2.2 | GO:0046332 | SMAD binding(GO:0046332) |
0.4 | 1.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 3.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.4 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 10.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.4 | 1.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 1.8 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 1.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.3 | 7.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 4.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 1.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 3.8 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 7.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 2.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 9.7 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.3 | 2.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 2.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 7.2 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 1.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 0.7 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 1.0 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 0.7 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.3 | 4.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 5.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 0.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.3 | 1.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 1.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.3 | 2.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 2.0 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 0.3 | GO:0046979 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 4.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 4.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.3 | 1.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 3.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 0.3 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.3 | 3.9 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 1.9 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.3 | 1.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.3 | 1.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 0.6 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 1.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 4.5 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 0.6 | GO:0018646 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 0.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 1.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 5.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 0.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.3 | 14.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 2.8 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 12.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 7.3 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.3 | 1.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 3.0 | GO:0015250 | water channel activity(GO:0015250) |
0.3 | 4.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 1.5 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.3 | 1.8 | GO:0070251 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 1.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 2.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.3 | 1.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 2.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 0.9 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 1.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 5.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.3 | 0.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 1.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 0.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.3 | 2.0 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 0.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 1.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 0.6 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.3 | 7.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 2.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 1.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 1.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 1.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 7.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 2.5 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 0.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 0.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.3 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 1.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 13.3 | GO:0051020 | GTPase binding(GO:0051020) |
0.3 | 15.9 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.3 | 0.8 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 1.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 1.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 24.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 1.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 12.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 0.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 0.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.3 | 2.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 1.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 0.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 0.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 2.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 0.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 1.0 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 8.2 | GO:0008144 | drug binding(GO:0008144) |
0.2 | 2.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 2.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 4.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 2.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 7.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.2 | 2.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 0.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 2.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 2.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 3.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.2 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 0.5 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.2 | 4.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 7.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 10.7 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 1.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 2.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 8.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.2 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 3.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 1.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.7 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 1.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 2.8 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 3.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 5.3 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 0.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 5.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 1.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 8.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 1.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 31.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 5.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.2 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.2 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 2.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.6 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 1.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 1.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 1.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 3.1 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.2 | 0.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.4 | GO:0042287 | MHC protein binding(GO:0042287) |
0.2 | 4.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 2.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.2 | 26.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.2 | 2.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 0.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 5.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 4.4 | GO:0005506 | iron ion binding(GO:0005506) |
0.2 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 0.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 10.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 4.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 2.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 68.8 | GO:0005198 | structural molecule activity(GO:0005198) |
0.2 | 0.9 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 6.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 4.0 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.2 | 0.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 1.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 13.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 1.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 1.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 1.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 10.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.2 | 2.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.3 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 0.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 29.2 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 1.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 1.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 19.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 1.1 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 14.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 9.4 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 2.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 2.2 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 1.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.6 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 9.7 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 2.2 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.6 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 26.7 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 4.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 3.9 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 1.8 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.1 | 0.8 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 32.7 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 1.2 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.2 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 1.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.3 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 10.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 7.3 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.1 | GO:0099516 | ion antiporter activity(GO:0099516) |
0.1 | 3.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 4.1 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 1.0 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 13.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.2 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.1 | 0.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 4.7 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 6.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 38.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.6 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.1 | 0.8 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.6 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.9 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 1.3 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 1.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.0 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 5.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.5 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.0 | GO:0018501 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.0 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 46.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.7 | 26.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.4 | 2.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.2 | 39.6 | PID ARF6 PATHWAY | Arf6 signaling events |
1.2 | 7.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.2 | 42.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.2 | 50.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.1 | 2.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.1 | 25.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.1 | 22.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.0 | 10.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.0 | 27.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.9 | 14.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.9 | 6.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 32.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.9 | 8.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.9 | 2.7 | PID EPO PATHWAY | EPO signaling pathway |
0.9 | 12.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.8 | 14.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.8 | 11.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 18.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.8 | 9.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 2.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.8 | 3.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.8 | 16.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.7 | 8.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.7 | 16.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.7 | 9.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.7 | 2.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 20.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 10.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.6 | 12.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.6 | 8.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.6 | 15.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.6 | 5.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 18.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.6 | 2.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.6 | 13.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 9.4 | PID MYC PATHWAY | C-MYC pathway |
0.6 | 14.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.6 | 1.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 13.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 18.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 3.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.5 | 21.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 8.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 11.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 2.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 7.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 4.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 2.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 1.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 1.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.5 | 2.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.5 | 4.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.5 | 8.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 2.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 1.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 6.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 10.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 0.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 18.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 4.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 10.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 2.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 8.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 29.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 61.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 11.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 10.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 11.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 9.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 5.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 3.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 7.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 2.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 6.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 1.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 2.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 1.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 11.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 2.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 2.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 18.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 3.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 2.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 1.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 3.9 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 7.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 6.5 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 2.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 1.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 3.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 5.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 1.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 8.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 1.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 1.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 0.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 2.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 1.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 32.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 2.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 1.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 1.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 4.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 1.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 0.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 1.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 2.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 18.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.5 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 6.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
3.0 | 3.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.7 | 26.7 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
2.3 | 18.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.3 | 22.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.8 | 7.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.7 | 20.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.7 | 11.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.6 | 3.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.6 | 15.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.5 | 45.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.4 | 14.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.4 | 43.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.4 | 2.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.3 | 20.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.3 | 17.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.2 | 15.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.1 | 26.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.1 | 12.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.1 | 2.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.1 | 15.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.1 | 10.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.1 | 22.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.1 | 8.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.1 | 9.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.1 | 45.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.1 | 9.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.1 | 14.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.0 | 4.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
1.0 | 10.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.0 | 17.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.0 | 12.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.0 | 10.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.0 | 17.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.0 | 16.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.0 | 7.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.0 | 1.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
1.0 | 1.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.0 | 1.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.0 | 12.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.9 | 0.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.9 | 10.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.9 | 21.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.9 | 17.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.9 | 13.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.9 | 6.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.9 | 7.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.9 | 9.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.9 | 4.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.9 | 14.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.8 | 0.8 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.8 | 10.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.8 | 7.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 3.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.8 | 12.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.8 | 23.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 6.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.8 | 3.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 12.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.7 | 7.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.7 | 5.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.7 | 21.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.7 | 13.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.7 | 7.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.7 | 3.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.7 | 9.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.7 | 19.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.7 | 7.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.7 | 3.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.7 | 8.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.7 | 6.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 3.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 14.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.6 | 6.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 5.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.6 | 1.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.6 | 9.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.6 | 3.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.6 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 1.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 2.5 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.6 | 6.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.6 | 11.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.6 | 8.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 7.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.6 | 5.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 3.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.6 | 2.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.6 | 10.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.6 | 1.8 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.6 | 16.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.6 | 2.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 8.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.6 | 4.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.6 | 2.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 10.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 10.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.6 | 6.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.6 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.6 | 23.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 3.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 19.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.5 | 5.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 5.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.5 | 2.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.5 | 4.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 4.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.5 | 10.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.5 | 3.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.5 | 5.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 8.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.5 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 6.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 13.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 6.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 4.6 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.5 | 4.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 5.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 2.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 8.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 4.4 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.4 | 3.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 19.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 14.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 3.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 3.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.4 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 12.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 8.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.4 | 7.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 2.5 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.4 | 4.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.4 | 2.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.4 | 0.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 5.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 0.8 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.4 | 8.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 3.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 0.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 5.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 17.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.4 | 6.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.4 | 16.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.4 | 6.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 13.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 23.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 5.1 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.4 | 25.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.4 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 48.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 3.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 6.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 10.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.4 | 17.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 4.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 2.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.3 | 2.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 3.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.3 | 3.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 2.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 11.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 18.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 6.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 2.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 8.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 2.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 21.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 0.6 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 4.4 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.3 | 0.3 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.3 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 2.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 1.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 7.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 0.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 3.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 3.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 24.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 5.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.3 | 0.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 2.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 3.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 3.7 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 3.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 3.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 2.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 1.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 1.7 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.2 | 5.9 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 3.4 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
0.2 | 2.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 2.0 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 1.3 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.2 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 21.5 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.2 | 9.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 7.9 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.2 | 1.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 1.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 2.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 0.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 1.6 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 1.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 7.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 1.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 1.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 4.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 3.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 2.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 1.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 4.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 1.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 8.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 1.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.5 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 7.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 1.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.2 | 0.6 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.2 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 3.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 0.9 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.2 | 0.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 3.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 5.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 3.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.7 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 2.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 1.7 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 3.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.5 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 10.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 4.4 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.4 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 4.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 1.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.6 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.3 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.0 | 0.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.0 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |